Phase 2 Startpositive

Phase 2 Start: A Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Safety and Tolerabili

Indication
Asthma (Diagnosis)

Other upcoming events for KYMR

Phase 2 ReadoutPhase 2 Readout: kt-621
Phase 2 ReadoutPhase 2 Readout: kt-621

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Start: A Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Safety and Tolerabili — KYMR Phase 2 Start | BioSniper